Publication of Pricing Supplement

State Of Israel
15 November 2023
 


State of Israel - Ministry of Finance

Publication of Pricing Supplement

The following Pricing Supplement is available for viewing:

Pricing Supplement dated 15 November 2023 in respect of an issue by the State of Israel (the Issuer) of USD700,000,000 6.500 per cent. Notes due 6 November 2031 (the Notes) to be consolidated and form a single Series with the outstanding USD800,000,000 6.500 per cent. Notes due 6 November 2031 issued on 6 November 2023.

 

The Notes are issued under the Euro Medium Term Note Programme established by the Issuer. The Pricing Supplement must be read in conjunction with the Offering Circular dated 15 July 2021 (the Offering Circular) in relation to the Programme.

To view the Pricing Supplement in respect of the Notes, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6039T_1-2023-11-15.pdf

To view the Offering Circular, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6039T_2-2023-11-15.pdf

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement is not for distribution in the United States.

Please note that the information contained in the Pricing Supplement and the Offering Circular may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Pricing Supplement and/or the Offering Circular) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Pricing Supplement and/or the Offering Circular is not addressed. Prior to relying on the information contained in the Pricing Supplement and/or the Offering Circular, you must ascertain from the Pricing Supplement and the Offering Circular whether or not you are part of the intended addressees of, and eligible to view, the information contained therein. 

In particular, none of this announcement, the Pricing Supplement or the Offering Circular shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities referred to in the Pricing Supplement and/or the Offering Circular (the Securities) have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the Securities may not be offered or sold directly or indirectly within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. Any forwarding, distribution or reproduction of the Offering Circular in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the Securities in the United States.

The Pricing Supplement and/or the Offering Circular has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Issuer, its advisers nor any person who controls any of them nor any representative, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Pricing Supplement and/or the Offering Circular made available to you in electronic format and the hard copy version available to you on request from the Issuer.

For further information, please contact:

Ministry of Finance of Israel

1 Kaplan St.
Hakiria
Jerusalem 9195015
Israel

Telephone: +972-2-5317555

Fax: +972-2-5695387

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings